New processing approaches in calcium phosphate cements and their applications in regenerative medicine

Acta Biomaterialia

Volumn 6, Issue 8, 2010, Pages 2863-2873

  Ginebra, M P ^a,b   Espanol, M ^a,b   Montufar, E B ^a,b,c   Perez, R A ^a,b   Mestres, G ^a,b,c  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^c INSTITUTE FOR BIOENGINEERING OF CATALONIA IBEC   (Spain)

Author keywords

Bone regeneration; Calcium phosphate cements; Granules; Microcarriers; Scaffolds

Indexed keywords

BONE; BONE CEMENT; CALCIUM PHOSPHATE; CEMENTS; HYDROXYAPATITE; MATERIALS HANDLING; PRECIPITATION (CHEMICAL); SETTING;

BONE REGENERATION; CALCIUM PHOSPHATE CEMENT; CEMENT PASTE; DISSOLUTION-PRECIPITATION PROCESS; HYDROXYAPATITE NANOCRYSTALS; KEY FEATURE; MICROCARRIERS; PROCESSING APPROACH; REGENERATIVE MEDICINE; SETTING REACTIONS;

SOLUTIONS;

BIOMATERIAL; CALCIUM DERIVATIVE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE CEMENT; CALCIUM PHOSPHATE CERAMIC; CARBON DIOXIDE; DICALCIUM PHOSPHATE ANHYDROUS; FOAMING AGENT; GELATIN; HYDROGEN PEROXIDE; HYDROXYAPATITE; HYDROXYPROPYLMETHYLCELLULOSE; POLYGLACTIN; POLYURETHAN; SURFACTANT; TETRACALCIUM PHOSPHATE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; BONE CEMENT; TISSUE SCAFFOLD;

BIOCOMPATIBILITY; BIODEGRADATION; BIOLEACHING; BONE GRAFT; CHEMICAL REACTION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; FOAMING; FREEZE DRYING; GAS; GRANULE CELL; HUMAN; HYDROLYSIS; IMPLANTATION; IN VIVO CULTURE; LIQUID PHASE MICROEXTRACTION; MICROCARRIER CULTURE; NANOFABRICATION; NONHUMAN; POLYMERIZATION; POWDER; PRIORITY JOURNAL; PROCESS DEVELOPMENT; REGENERATIVE MEDICINE; REVIEW; SURFACE PROPERTY; SYNTHESIS; TISSUE ENGINEERING; MATERIALS TESTING; METHODOLOGY;

BONE CEMENTS; CALCIUM PHOSPHATES; MATERIALS TESTING; REGENERATIVE MEDICINE; TISSUE SCAFFOLDS;

EID: 77956623191     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2010.01.036     Document Type: Review

References (105)

1. Ginebra MP. Calcium phosphate bone cements. In: Deb S, editor. Orthopaedic bone cements. Cambridge: Woodhead Publishing Limited; 2008. p. 206-30.
2. Lewis G. Injectable bone cements for use in vertebroplasty and kyphoplasty: state-of-the-art review. J Biomed Mater Res B 2006;76:456-68.
3. Bohner M, Gbureck U, Barralet JE. Technological issues for the development of more efficient calcium phosphate bone cements: a critical assessment. Biomaterials 2005;26:6423-9.
4. de Bruijn JD, Shankar K, Yuan H, Habibovic P. Osteoinduction and its evaluation. In: Kokubo T, editor. Bioceramics and their clinical applications. Cambridge: Woodhead Publishing Limited; 2008. p. 199-219.
5. Ginebra MP, Traykova T, Planell JA. Calcium phosphate cements as bone drug delivery systems: a review. J Control Release 2006;113:102-10.
6. Markovic M, Takagi S, Chow LC. Formation of macropores in calcium phosphate cements through the use of mannitol crystals. Key Eng Mater 2001;192-195:773-6.
7. Takagi S, Chow LC. Formation of macropores in calcium phosphate cement implants. J Mater Sci Mater Med 2002;12:135-9.
8. Barralet JE, Grover L, Gaunt T, Wright AJ, Gibson IR. Preparation of macroporous calcium phosphate cement tissue engineering scaffold. Biomaterials 2002;23:3063-72.
9. Fernández E, Vlad MD, Gel MM, López J, Torres R, Cauich JV, et al. Modulation of porosity in apatitic cements by the use of α-tricalcium phosphate-calcium sulphate dihydrate mixtures. Biomaterials 2005;26:3395-404.
10. Cama G, Barberis F, Botter R, Cirillo P, Capurro M, Quarto R, et al. Preparation and properties of macroporous brushite bone cements. Acta Biomater 2009;5:2161-8.
11. Xu HHK, Quinn JB. Calcium phosphate cement containing resorbable fibers for short-term reinforcement and macroporosity. Biomaterials 2002;23:193-202.
12. Zuo Y, Yang F, Wolke JGC, Li Y, Jansen JA. Incorporation of biodegradable electrospun fibers into calcium phosphate cement for bone regeneration. Acta Biomater 2010;6:1238-47.
13. Xu HHK, Eichmiller FC, Giuseppetti AA. Reinforcement of a self-setting calcium phosphate cement with different fibers. J Biomed Mater Res 2000;52:107-14.
14. Xu HHK, Eichmiller FC, Barndt PR. Effects of fiber length and volume fraction on the reinforcement of calcium phosphate cement. J Mater Sci Mater Med 2001;12:57-65.
15. Xu HHK, Quinn JB, Takagi S, Chow LC, Xu HHK, Quinn JB, et al. Synergistic reinforcement of in situ hardening calcium phosphate composite scaffold for bone tissue engineering. Biomaterials 2004;25:1029-37.
16. Xu HHK, Simon CG. Self-hardening calcium phosphate cement-mesh composite: reinforcement, macropores, and cell response. J Biomed Mater Res A 2004;69:267-78.
17. Xu HHK, Simon Jr CG. Fast setting calcium phosphate-chitosan scaffold: mechanical properties and biocompatibility. Biomaterials 2005;26:1337-48.
18. Xu HHK, Weir MD, Burguera EF, Fraser AM. Injectable and macroporous calcium phosphate cement scaffold. Biomaterials 2006;27:4279-87.
19. Ruhé PQ, Hedberg EL, Padron NT, Spauwen PH, Jansen JA, Mikos AG. RhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium- phosphate cement composites. J Bone Joint Surg Am 2003;85:75-81.
20. Ruhé PQ, Boerman OC, Russel FGM, Spauwen PHM, Mikos AG, Jansen JA. Controlled release of rhBMP-2 loaded poly (DL-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release 2005;106:162-71.
21. Plachokova A, Link D, van den Dolder J, van den Beucken J, Jansen JA. Bone regenerative properties of injectable PGLA-CaP composite with TGF-β1 in a rat augmentation model. J Tissue Eng Regen Med 2007;1:457-64.
22. Habraken WJEM, Wolke JGC, Mikos AG, Jansen JA. PLGA microsphere/calcium phosphate cement composites for tissue engineering: in vitro release and degradation characteristics. J Biomater Sci Polym E 2008;19:1171-88.
23. Habraken WJEM, Wolke JGC, Mikos AG, Jansen JA. Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics. J Biomater Sci Polym E 2006;17:1057-74.
24. Bodde EWH, Habraken WJEM, Mikos AG, Spauwen PHM, Jansen JA. Effect of polymer molecular weight on the bone biological activity of biodegradable polymer/calcium phosphate cement composites. Tissue Eng A 2009;15:3184-91.
25. Ruhé PQ, Hadberg EL, Padron NT, Spauwen PHM, Jansen JA, Mikos AG. Biocompatibility and degradation of poly (DL-lactic-co-glycolic acid)/calcium phosphate cement composites. J Biomed Mater Res A 2005;74:533-44.
26. Link DP, van den Dolder J, Jurgens WJFM, Wolke JGC, Jansen JA. Mechanical evaluation of implanted calcium phosphate cement incorporated with PLGA microparticles. Biomaterials 2006;27:4941-7.
27. Habraken WJEM, de Jonge LT, Wolke JGC, Yubao L, Mikos AG, Jansen JA. Introduction of gelatine microspheres into an injectable calcium phosphate cement. J Biomed Mater Res A 2008;87:643-55.
28. Habraken WJEM, Wolke JGC, Mikos AG, Jansen JA. Porcine gelatine microsphere/calcium phosphate cement composites: an in vitro degradation study. J Biomed Mater Res B 2009;91:555-61.
29. Link DP, van den Dolder J, van den Beucken J, Wolke JGC, Mikos AG, Jansen JA. Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-β1 loaded gelatine microparticles. Biomaterials 2008;29:675-82.
30. Link DP, van den Dolder J, van den Beucken J, Habraken WJEM, Soede A, Boerman OC, et al. Evaluation of an orthotopically implanted calcium phosphate cement containing gelatine microparticles. J Biomed Mater Res A 2009;90:372-9.
31. Habraken WJEM, Boerman OC, Wolke JGC, Mikos AG, Jansen JA. In vitro growth factor release from injectable calcium phosphate cements containing gelatine microspheres. J Biomed Mater Res A 2009;91:614-22.
32. Almirall A, Larrecq G, Delgado JA, Martinez S, Planell JA, Ginebra MP. Fabrication of low temperature macroporous hydroxyapatite scaffolds by foaming and hydrolysis of an α-TCP paste. Biomaterials 2004;25:3671-80.
33. Hesaraki S, Sharifi D. Investigation of an effervescent additive as porogenic agent for bone cement macroporosity. Biomed Mater Eng 2007;17:29-38.
34. Hesaraki S, Zamanian A, Moztarzadeh F. The influence of the acidic component of the gas-foaming porogen used in preparing an injectable porous calcium phosphate cement on its properties: acetic acid versus citric acid. J Biomed Mater Res B 2008;86:208-16.
35. del Real RP, Wolke JGC, Vallet-Regi M, Jansen JA. A new method to produce macropores in calcium phosphate cements. Biomaterials 2002;23:3673-80.
36. del Real RP, Ooms E, Wolke JGC, Vallet-regí M, Jansen JA. In vivo bone response to porous calcium phosphate cement. J Biomed Mater Res A 2003; 65A: 30-6.
37. Ruhé PQ, Hadberg EL, Padron NT, Spauwen PHM, Jansen JA, Mikos AG. Porous poly (DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng 2006;12:789-800.
38. Muth CM, Shank ES. Primary care: gas embolism. N Engl J Med 2000;342:476-82.
39. Ginebra MP, Delgado JA, Harr I, Almirall A, Del Valle S, Planell JA. Factors affecting the structure and properties of an injectable self-setting calcium phosphate foam. J Biomed Mater Res A 2007;80:351-61.
40. Del Valle S, Miño N, Muñoz F, González A, Planell JA, Ginebra MP. In vivo evaluation of an injectable macroporous calcium phosphate cement. J Mater Sci Mater Med 2007;18:353-61.
41. Montufar EB, Traykova T, Schacht E, Ambrosio L, Santin M, Planell JA, et al. Self-hardening calcium deficient hydroxyapatite/gelatine foams for bone regeneration. J Mater Sci Mater Med 2009. doi:10.1007/s10856-009-3918-7.
42. Sarda S, Nilsson M, Balcells M, Fernández E. Influence of surfactant molecules as air-entraining agent for bone cement macroporosity. J Biomed Mater Res A 2003;65:215-21.
43. Montufar EB, Traykova T, Gil C, Harr I, Almirall A, Aguirre A, et al. Foamed surfactant solution as a template for self-setting injectable hydroxyapatite scaffolds for bone regeneration. Acta Biomater 2010;6:876-85.
44. Montufar EB, Gil C, Traykova T, Ginebra MP, Planell JA. Foamed betatricalcium phosphate scaffolds. Key Eng Mater 2008;361-363:323-6.
45. Bohner M. Implant comprising calcium cement and hydrophobic liquid. US Patent No. 6, 642, 285 B1; 2003.
46. Binks BP. Emulsion-recent advances in understanding. In: Binks BP, editor. Modern aspects of emulsions science. Cambridge: The Royal Society of Chemistry; 1998. p. 5-40.
47. Bohner M. Calcium phosphate emulsions: possible applications. Key Eng Mater 2001;192-195:765-8.
48. Bohner M, van Lenthe GH, Grünenfelder S, Hirsiger W, Evison R, Müller R. Synthesis and characterization of porous β-tricalcium phosphate blocks. Biomaterials 2005;26:6099-105.
49. von Doernberg MC, von Rechenberg B, Bohner M, Grünenfelder S, van Lenthe GH, Müller R, et al. In vivo behavior of calcium phosphate scaffolds with four different pore sizes. Biomaterials 2006;27:5186-98.
50. Deville S. Freeze-casting of porous ceramics: a review of current achievements and issues. Adv Eng Mater 2008;10:55-169.
51. Qi X, Ye J, Wang Y. Alginate/poly (lactic-co-glycolic acid)/calcium phosphate cement scaffold with oriented pore structure for bone tissue engineering. J Biomed Mater Res A 2009;89:980-7.
52. Panzavolta S, Fini M, Nicoletti A, Bracci B, Rubini K, Giardino R, et al. Porous composite scaffolds based on gelatine and partially hydrolyzed α-tricalcium phosphate. Acta Biomater 2009;5:636-43.
53. Miao X, Hu Y, Liu J, Wong AP. Porous calcium phosphate ceramics prepared by coating polyurethane foams with calcium phosphate cements. Mater Lett 2004;58:397-402.
54. Miao X, Lim WK, Huang X, Chen Y. Preparation and characterization of interpenetrating phased TCP/HA/PLGA composites. Mater Lett 2005;59:4000-5.
55. Miao X, Tan LP, Tan LS, Huang X. Porous calcium phosphate ceramics modified with PLGA-bioactive glass. Mater Sci Eng C 2007;27:274-9.
56. 2 foaming with PU sponge and modified with PLGA and bioactive glass. J Biomater Appl 2007;21:351-74.
57. Charriere E, Lemaitre J, Zysset Ph. Hydroxyapatite cement scaffolds with controlled macroporosity: fabrication protocol and mechanical properties. Biomaterials 2003;24:809-17.
58. Li X, Li D, Lu B, Tang Y, Wang L, Wang Z. Design and fabrication of CAP scaffolds by indirect solid free form fabrication. Rapid Prototyping J 2005;11:312-8.
59. Li X, Li D, Lu B, Wang L, Wang Z. Fabrication and evaluation of calcium phosphate cement scaffold with controlled internal channel architecture and complex shape. Proc Inst Mech Eng H 2007;221:951-8.
60. Guo D, Xu K, Han Y. The in situ synthesis of biphasic calcium phosphate scaffolds with controllable compositions, structures, and adjustable properties. J Biomed Mater Res A 2009;88:43-52.
61. Leong KF, Cheah CM, Chua CK. Solid freeform fabrication of threedimensional scaffolds for engineering replacement tissues and organs. Biomaterials 2003;24:2363-78.
62. Klammert U, Reuther T, Jahn C, Kraski B, Kubler AC, Gbureck U. Cytocompatibility of brushite and monetite cell culture scaffolds made by three-dimensional powder printing. Acta Biomater 2009;5:727-34.
63. Gbureck U, Hölzel T, Klammert U, Würzler K, Müller FA, Barralet JE. Resorbable dicalcium phosphate bone substitutes prepared by 3D powder printing. Adv Funct Mater 2007;17:3940-5.
64. Habibovic P, Gbureck U, Doillon CJ, Bassett DC, van Blitterswijk CA, Barralet JE. Osteoconduction and osteoinduction of low-temperature 3D printed bioceramic implants. Biomaterials 2008;29:944-53.
65. Gbureck U, Hzölzel T, Doillon CJ, Müller FA, Barralet JE. Direct printing of bioceramic implants with spatially localized angiogenic factors. Adv Mater 2007;19:795-800.
66. Gonda Y, Ioku K, Shibata Y, Okuda T, Kawachi G, Kamitakahara M, et al. Stimulatory effect of hydrothermally synthesized biodegradable hydroxyapatite granules on osteogenesis and direct association with osteoclasts. Biomaterials 2009;30:4390-400.
67. Bohner M, Baumgart F. Theoretical model to determine the effects of geometrical factors on the resorption of calcium phosphate bone substitutes. Biomaterials 2004;25:3569-82.
68. Malda J, Frondoza CG. Microcarriers in the engineering of cartilage and bone. Trends Biotechnol 2006;24:299-304.
69. Torquato S, Truskett TM, Debenedetti PG. Is random close packing of spheres well defined? Phys Rev Lett 2000;84:2064-7.
70. Misiek DJ, Kent JN, Carr RF. Soft tissue responses to hydroxylapatite particles of different shapes. J Oral Maxillofac Surg 1984;42:150-60.
71. Chang BS, Lee CK, Hong KS, Youn HJ, Ryu HS, Chung SS, et al. Osteoconduction at porous hydroxyapatite with various pore configurations. Biomaterials 2000;21:1291-8.
72. Tamimi F, Lopez-Cabarcos E, Rubio-Retama J, Torres-Garcia J. Monetite matrices and their application in bone regeneration. Patent Application No. WO 077210; 2009.
73. Tamimi F, Lopez-Cabarcos E, Blanco-Perez L, Rueda-Rodriguez C, Fernandez-Tresguerres I, Torres-Garcia J. Granulado de cemento de brushita fraguado con ácido glicólico para regeneración ósea. ES Patent No. 200503094; 2005.
74. Tamimi F, Torres Garcia J, Tresguerres I, Lopez Cabarcos E, Jerez-Blanco L. Bone augmentation in rabbit calvarie: comparative study between Bio-Oss and a novel b-TCP/DCPD granulate. J Clin Periodontol 2006;33:922-8.
75. Tamimi F, Torres-Garcia J, Kathan C, Baca R, Clemente C, Blanco-Perez L, et al. Bone regeneration in rabbit calvaria with novel monetite granules. J Biomed Mater Res A 2008;87:980-5.
76. Tamimi F, Torres-Garcia J, Tresguerres I, Blanco-Perez L, Lopez-Cabarcos E. Vertical bone augmentation with granulated brushite cement set in glycolic acid. J Biomed Mater Res A 2007;81:93-102.
77. Tas AC. Method of preparing porous calcium phosphate granules. US Patent Application No. 0260115 A1; 2005.
78. Tas AC. Preparation of porous apatite granules from calcium phosphate cement. J Mater Sci Mater Med 2007;19:2231-9.
79. Tas AC. Preparation of self-setting cement-based micro- and macroporous granules of carbonated apatitic calcium phosphate. Ceram Eng Sci Proc 2007;27:49-60.
80. Tas AC. Method of preparing porous calcium phosphate morsels and granules via gelatine processing. US Patent Application No. 0076685 A1; 2004.
81. Perez RA, Altankov G, Ginebra MP. Calcium phosphate cement microcarriers. Amsterdam: World Biomaterials Congress; 2008.
82. Shen H, Hu X, Yang F, Bei J, Wang S. An injectable scaffold: rhBMP-2-loaded poly (lactide-co-glycolide)/hydroxyapatite composite microspheres. Acta Biomater 2010;6:455-65.
83. Flautre B, Pasquier G, Blary MC, Anselme K, Hardouin P. Evaluation of hydroxyapatite powder coated with collagen as an injectable bone substitute: microscopic study in rabbit. J Mater Sci Mater Med 1996;7:63-7.
84. Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004;282:1-18.
85. Komlev VS, Barinov SM, Koplik EV. A method to fabricate porous spherical hydroxyapatite granules intended for time-controlled drug release. Biomaterials 2002;23:3449-54.
86. Hong Y, Gong Y, Gao C, Shen J. Collagen-coated polylactide microcarriers/chitosan hydrogel composite: injectable scaffold for cartilage regeneration. J Biomed Mater Res 2007; 85A: 628-37.
87. Shelton RM, Liu Y, Cooper PR, Gbureck U, German MJ, Barralet JE. Bone marrow cell gene expression and tissue construct assembly using octacalcium phosphate microscaffolds. Biomaterials 2006;27:2874-81.
88. Lemaitre J, Pittet C, Brendlen D. Pasty or liquid multiple constituent compositions for injectable calcium phosphate cements. US Patent No. 7, 407, 542 B2; 2008.
89. Dorozhkin SV. Calcium orthophosphates cements and concretes. Materials 2009;2:221-91.
90. Xu HHK, Carey LE, Simon Jr CG. Premixed macroporous calcium phosphate cement scaffold. J Mater Sci Mater Med 2007;18:1345-53.
91. Grover LM, Hofmann MP, Gbureck U, Kumarasami B, Barralet JE. Frozen delivery of brushite calcium phosphate cements. Acta Biomater 2008;4:1916-23.
92. Chow L, Takagi S. Dual-phase cement precursor systems for bone repair. US Patent Application No. 0092580 A1; 2007.
93. Carey LE, Xu HHK, Simon Jr CG, Takagi S, Chow LC. Premixed rapid-setting calcium phosphate composites for bone repair. Biomaterials 2005;26:5002-14.
94. Takagi S, Chow LC, Hirayama S, Sugawara A. Premixed calcium-phosphate cement pastes. J Biomed Mater Res B 2003;67:689-96.
95. Han B, Ma PW, Zhang LL, Yin YJ, Yao KD, Zhang FJ, et al. β-TCP/MCPM-based premixed calcium phosphate cements. Acta Biomater 2009;5:3165-77.
96. Wei J, Li Y. Injectable premixed cement of nanoapatite and polyamide composite. High Technol Lett 2002;2:18-22.
97. Chow LC, Takagi S. Premixed self-hardening bone graft pastes. US Patent Application No. 0263443 A1; 2006.
98. Chow LC, Takagi S. Premixed calcium phosphate cement pastes. US Patent No. 6, 793, 725 B2; 2004.
99. Ishikawa K, Miyamoto Y, Takechi M, Toh T, Kon M, Nagayama M, et al. Nondecay type fast-setting calcium phosphate cement: hydroxyapatite putty containing an increased amount of sodium alginate. J Biomed Mater Res A 1997;36:393-9.
100. Xu HHK, Carey LE, Simon Jr CG, Takagi S, Chow LC. Premixed calcium phosphate cements: synthesis, physical properties, and cell cytotoxicity. Dent Mater 2007;23:433-41.
101. Sugawara A, Chow LC, Takagi S, Chohayeb H. In vitro evaluation of the sealing ability of a CPC when used as aroot canal sealer-filler. J Endod 1990;16:162-5.
102. Sugawara A, Kusama K, Nishimura S, Nishiyama M, Moro I, Kudo I, et al. Histopathological reaction of a calcium phosphate cement root canal filler. J Hard Tissue Biol 1995;4:1-7.
103. Yoshikawa T, Suwa Y, Ohgushi H, Tamai S, Ichijima K. Self-setting hydroxyapatite cement as a carrier for bone-forming cells. Biomed Mater Eng 1996;6:345-51.
104. Simon CG, Guthrie WF, Wang FW. Cell seeding into calcium phosphate cement. J Biomed Mater Res A 2003;68:628-39.
105. Xu HHK, Weir MD, Simon CG. Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration. Dent Mater 2008;24:1212-22.